Xurocitam AG Tablet combines Alpha Glycerylphosphorylcholine (Alpha GPC) 250mg, a natural choline donor essential for acetylcholine synthesis, with Piracetam 800mg, a well-established nootropic agent that enhances neuronal metabolism and cerebral blood flow. This formulation is designed to support brain function, memory retention, and neuroprotection.
Clinically, this combination is used in cognitive impairment, memory loss, dementia, post-stroke recovery, and age-related neurological decline. Alpha GPC improves cholinergic neurotransmission, while Piracetam enhances neuronal plasticity and oxygen utilization in brain tissues, resulting in improved cognitive performance.
The tablet formulation ensures precise dosing, consistent bioavailability, and synergistic neurological action, making it suitable for neurology clinics, hospitals, rehabilitation centers, and specialty pharmacies. It is commonly prescribed as adjunct therapy in neurodegenerative and cerebrovascular conditions under medical supervision.
Xurocitam AG Tablet helps in improving memory, enhancing focus and alertness, supporting brain cell function, and protecting neurons from metabolic stress. Its clinically proven ingredients make it a reliable neuroprotective and cognitive-support therapy for long-term neurological care.